| FTV |
Report |
Revenue |
IN-LINE |
pred ~$1.085B vs. cons $1.080B |
MEDIUM |
| FTV |
Report |
Adjusted EPS |
BEAT |
pred ~$0.72 vs. cons $0.71 |
MEDIUM |
| FTV |
Report |
Core revenue growth |
BEAT |
pred ~5.1% vs. cons 5.0% |
MEDIUM |
| FTV |
Guide |
FY2026 adjusted EPS midpoint |
BETTER |
guide ~$3.00 vs. cons $2.99 (FY2026; predicted range $2.95-$3.05) |
MEDIUM |
| FTV |
Guide |
FY2026 core revenue growth midpoint |
BETTER |
guide ~3.5% vs. cons 3.0% (FY2026; predicted range 3%-4%) |
MEDIUM |
| FTV |
Guide |
Q3 2026 adjusted EPS |
LOWER |
guide ~$0.71 vs. cons $0.72 (Q3 2026) |
LOW |
| FTV |
Return |
Day-1 residual (stock − beta × S&P 500) |
+1.5% |
— |
LOW |
| FTV |
Return |
5-day cumulative residual |
+0.5% (FADE) |
Day-5 residual +0.5% vs. day-1 residual +1.5%: a modest FY2026 raise and stronger core-growth outlook support the initial move, but Q3 EPS below the ~$0.72 consensus and difficult Q4 selling-day comparisons limit out-period estimate revisions, causing part of the post-earnings gain to fade. |
LOW |